Your browser doesn't support javascript.
loading
Combined EBUS-IFB and EBUS-TBNA vs EBUS-TBNA Alone for Intrathoracic Adenopathy: A Meta-Analysis.
Agrawal, Abhinav; Ghori, Uzair; Chaddha, Udit; Murgu, Septimiu.
Afiliação
  • Agrawal A; Interventional Pulmonology, Division of Pulmonary, Critical Care, and Sleep Medicine, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York. Electronic address: abhinav72@gmail.com.
  • Ghori U; Interventional Pulmonology, Section of Pulmonary & Critical Care Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana.
  • Chaddha U; Interventional Pulmonology, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Murgu S; Interventional Pulmonology, Section of Pulmonary & Critical Care Medicine, University of Chicago Medicine, Chicago, Illinois.
Ann Thorac Surg ; 114(1): 340-348, 2022 07.
Article em En | MEDLINE | ID: mdl-33485918
ABSTRACT

BACKGROUND:

Endobronchial ultrasound (EBUS)-guided intranodal forceps biopsy (IFB) is considered complementary to EBUS-guided transbronchial needle aspiration (TBNA) (EBUS-TBNA) for patients with intrathoracic lymphadenopathy either when additional tissue is requested for comprehensive molecular testing or for suspected lymphoma and sarcoidosis. This systematic review and meta-analysis investigated the diagnostic yield and complications of combined EBUS-IFB and EBUS-TBNA compared with EBUS-TBNA alone.

METHODS:

A systematic search was performed of Medline, Embase, and Google Scholar for studies evaluating the use of EBUS-IFB for diagnosis of intrathoracic adenopathy, and the quality of each study was assessed using the Quality Assessment, Data abstraction and Synthesis-2 tool. Using inverse variance weighting, a meta-analysis of diagnostic yield estimations was performed. The complications related to the procedure were also reviewed.

RESULTS:

Six observational studies with 443 patients undergoing 467 biopsies were included in the final analysis. Meta-analysis yielded a pooled overall diagnostic yield of 67% (312 of 467) for EBUS-TBNA and 92% (428 of 467) for EBUS-TBNA in combination with EBUS-IFB, with an inverse variance-weighted odds ratio of 5.87 (95% confidence interval, 3081 to 9.04; P < .00001) and an I2 of 15%. The overall complications included pneumomediastinum (1%), bleeding (0.8%), and respiratory failure (0.6%). The funnel plot analysis illustrated no major publication bias. Subgroup analysis showed increased diagnostic yield for lymphoma (86% vs 30%; P = .03) and sarcoidosis (93% vs 58%; P < .00001).

CONCLUSIONS:

The addition of EBUS-IFB to EBUS-TBNA improves the overall diagnostic yield of sampling intrathoracic adenopathy when compared with EBUS-TBNA alone. The complication rates of the combined approach are higher than with EBUS-TBNA, but they are reportedly lower than with transbronchial or surgical biopsies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Linfadenopatia / Linfoma Tipo de estudo: Diagnostic_studies / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Thorac Surg Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Linfadenopatia / Linfoma Tipo de estudo: Diagnostic_studies / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Thorac Surg Ano de publicação: 2022 Tipo de documento: Article